X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2493) 2493
Publication (185) 185
Book Review (33) 33
Book Chapter (15) 15
Conference Proceeding (6) 6
Book / eBook (5) 5
Dissertation (2) 2
Newsletter (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1694) 1694
index medicus (1226) 1226
animals (1148) 1148
serine proteinase inhibitors - therapeutic use (880) 880
male (642) 642
female (540) 540
proteins (511) 511
mice (460) 460
serine (450) 450
multidisciplinary sciences (402) 402
research article (377) 377
medicine (360) 360
serine proteinase inhibitors - pharmacology (360) 360
proteases (328) 328
science (322) 322
serine proteinase (318) 318
research (308) 308
middle aged (278) 278
apoptosis (262) 262
rats (261) 261
cancer (257) 257
cell biology (243) 243
protease inhibitors (243) 243
enzymes (241) 241
inflammation (241) 241
health aspects (239) 239
biochemistry (232) 232
gene expression (232) 232
expression (230) 230
biology (226) 226
biochemistry & molecular biology (224) 224
pharmacology & pharmacy (222) 222
activation (219) 219
serine endopeptidases - metabolism (213) 213
adult (208) 208
kinases (200) 200
signal transduction (199) 199
aged (198) 198
treatment outcome (193) 193
oncology (191) 191
protease (186) 186
article (182) 182
immunology (181) 181
thrombin (179) 179
analysis (175) 175
surgery (172) 172
genetic aspects (169) 169
rodents (169) 169
physiological aspects (168) 168
phosphorylation (167) 167
cell line, tumor (156) 156
disease models, animal (154) 154
respiratory system (153) 153
aprotinin - therapeutic use (152) 152
inhibition (149) 149
care and treatment (148) 148
biology and life sciences (145) 145
inhibitors (142) 142
proteinase inhibitors (142) 142
serine proteases (141) 141
amino acid sequence (133) 133
peptides (128) 128
cardiac & cardiovascular systems (123) 123
serine-protease (123) 123
mutation (120) 120
risk factors (120) 120
serine proteinase inhibitors - chemistry (120) 120
hematology (117) 117
cell line (116) 116
physiology (116) 116
proteolysis (116) 116
medicine and health sciences (114) 114
antiviral agents - therapeutic use (113) 113
chemistry, medicinal (113) 113
serine proteinase inhibitors - adverse effects (113) 113
serine proteinase inhibitors - administration & dosage (112) 112
molecular sequence data (111) 111
gastroenterology & hepatology (110) 110
peripheral vascular disease (108) 108
cytokines (107) 107
cardiopulmonary bypass (105) 105
protein-serine-threonine kinases - metabolism (105) 105
cells (104) 104
proteinase (104) 104
amino acids (103) 103
development and progression (103) 103
tumors (103) 103
cells, cultured (101) 101
medical research (101) 101
drug therapy, combination (100) 100
in-vitro (100) 100
therapy (98) 98
mice, inbred c57bl (96) 96
medicine, research & experimental (95) 95
time factors (95) 95
cell proliferation (94) 94
microbiology (92) 92
in-vivo (91) 91
molecular biology (90) 90
models, molecular (89) 89
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2422) 2422
Japanese (28) 28
Russian (14) 14
German (13) 13
French (8) 8
Italian (6) 6
Polish (4) 4
Spanish (4) 4
Chinese (2) 2
Dutch (2) 2
Swedish (2) 2
Czech (1) 1
Danish (1) 1
Korean (1) 1
Portuguese (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 03/2011, Volume 364, Issue 13, pp. 1195 - 1206
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2011, Volume 364, Issue 25, pp. 2405 - 2416
In patients with HCV infection and no previous treatment, the addition of telaprevir to peginterferon–ribavirin resulted in higher response rates than those... 
GENETIC-VARIATION | IL28B | MEDICINE, GENERAL & INTERNAL | HEPATOCELLULAR-CARCINOMA | GENOTYPE-1 PATIENTS | PEGINTERFERON ALPHA-2B | AMERICAN PATIENTS | ALPHA-2B PLUS RIBAVIRIN | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Polyethylene Glycols - adverse effects | Male | RNA, Viral - blood | Recombinant Proteins | Oligopeptides - adverse effects | Polyethylene Glycols - therapeutic use | Viral Load | Oligopeptides - therapeutic use | Serine Proteinase Inhibitors - therapeutic use | Young Adult | Serine Proteinase Inhibitors - adverse effects | Adult | Female | Drug Therapy, Combination | Hepacivirus - isolation & purification | Double-Blind Method | Antiviral Agents - therapeutic use | Interferon-alpha - therapeutic use | Logistic Models | Hepatitis C, Chronic - drug therapy | Sequence Analysis, DNA | Antiviral Agents - adverse effects | Aged | Interferon-alpha - adverse effects | Peginterferon alfa-2b | Patient outcomes | Genetic aspects | Hepatitis C | Drug therapy | Comparative analysis | Health aspects | Fees & charges | Antiretroviral drugs | Liver diseases | Clinical trials | Chronic infection | Employees | Infections | Proteinase inhibitors | Genomes | Ribonucleic acid--RNA | Patients | Ribavirin | Liver cancer | Genotype & phenotype | Hepatitis | Skin | Interferon | Genotypes | Pharmaceuticals
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2011, Volume 364, Issue 13, pp. 1207 - 1217
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2011, Volume 364, Issue 25, pp. 2417 - 2428
Journal Article
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 03/2012, Volume 35, Issue 6, pp. 647 - 662
Journal Article